Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

The impact of tumor molecular profile-directed treatment on survival in recurrent ovarian cancer. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a ...

"Endometrial hyperplasia and cancer are highly affected by obesity and lifestyle factors. Focusing on these factors in diverse communities will lead to our better understanding of these disparities.

Please provide your email address to receive an email when new articles are posted on . Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Bayer AG is conducting a ...

This content is provided by MedStar Washington Hospital Center. Endometrial cancer, also known as uterine cancer, accounts for seven percent of all cancers in women, according to the National Cancer ...

Relative conditional survival in 41,476 patients with ovarian cancer. Oxaliplatin plus continuous infusion topotecan: An ongoing phase II study for recurrent ovarian cancer—A New York Cancer ...

Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...

Endometrial cancer is a disease in which cancerous cells form in the tissues of the endometrium, which is part of the uterus. Many other health problems can also cause these signs. If you have any of ...

Hormonal therapy with an intrauterine device (IUD) led to complete tumor regression in two-thirds of women with early-stage endometrial cancer or precancerous lesions, a randomized pragmatic phase II ...